Prevalence and Assessment of Metabolic Syndrome in Reproductive-Age Women with Polycystic Ovarian Syndrome (Code-T0240)

Introduction: Polycystic Ovarian Syndrome (PCOS) is a common endocrine disorder in women of reproductive age, often associated with metabolic syndrome (MetS). MetS increases the risk of cardiovascular diseases, insulin resistance, and type 2 diabetes, making its early detection in PCOS crucial for better management and prevention of complications.

Aims and Objectives:

Aims:

  -To  study  the  clinical  profile  of  patients  with  PCOS .

 - To evaluate  and   study  the  prevalence  of  metabolic  syndrome  in  a  tertiary  care  hospital.

Objectives:

   1.To  define  a  patient  of  PCOS  as  per  Rotterdam’s  Criteria. 

   2.Evaluation  of  women  with  PCOS  should  exclude  alternate  androgen  excess   disorders and  risk  factors  for  mood disorders , obstructive  sleep  apnea ,diabetes  and  cardiovascular  disorders.

   3.To  study  the  history, clinical  characteristics, anthropology ,lipid  profile and  USG  features  of  the  patient. 

1. To correlate  and  analysis  the  above  and  compare  with  other  studies.

Methods: A cross-sectional observational study was conducted on reproductive-age women diagnosed with PCOS based on the Rotterdam criteria. MetS was diagnosed using the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) criteria. Clinical parameters such as body mass index (BMI), waist circumference, blood pressure, and biochemical markers including fasting glucose, lipid profile, and insulin resistance were analyzed. Statistical analysis was performed to determine the correlation between PCOS and MetS.

Results: The study is expected to reveal a high prevalence of MetS in PCOS patients, with obesity, insulin resistance, and dyslipidemia as key contributing factors. The findings emphasize the need for routine metabolic screening in PCOS management.

Conclusion: Early identification of MetS in PCOS patients can aid in timely interventions, reducing long-term cardiovascular and metabolic risks. Lifestyle modifications and targeted therapies are essential in improving outcomes for affected individuals.

Keywords: PCOS, Metabolic Syndrome, Insulin Resistance, Obesity, Cardiovascular Risk, Reproductive Health